Voyager Therapeutics Inc (NASDAQ:VYGR)

7.75
Delayed Data
As of 3:59pm ET
 +0.03 / +0.39%
Today’s Change
4.77
Today|||52-Week Range
14.34
+27.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$338.0M

Company Description

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Contact Information

Voyager Therapeutics, Inc.
64 Sidney Street
Cambridge Massachusetts 02139
P:(857) 259-5340
Investor Relations:

Employees

Shareholders

Other institutional39.68%
Individual stakeholders29.12%
Mutual fund holders19.99%

Top Executives

Alfred W. SandrockPresident, Chief Executive Officer & Director
Robin SwartzChief Operating Officer
Peter P. PfreundschuhChief Financial & Accounting Officer
Todd CarterChief Scientific Officer
Julie BurekVice President-Finance